PATRICIA CARMEN MUÑOZ GARCÍA-rekin lankidetzan egindako argitalpenak (38)

2024

  1. Addressing catheter lock therapy: Does heparin reduce the bioactivity of dalbavancin when together in solution during freezing?

    Enfermedades Infecciosas y Microbiologia Clinica

  2. Impact of an interventional bundle on complications associated with peripheral venous catheters in elderly patients

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 4, pp. 703-712

  3. Infectious complications following major heart surgery from the day of the surgery to hospital discharge

    BMC Infectious Diseases, Vol. 24, Núm. 1

2023

  1. A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic

    BMC Microbiology, Vol. 23, Núm. 1

  2. Cytomegalovirus reactivation in patients diagnosed with severe COVID-19: A point prevalence study in a general hospital

    Revista Espanola de Quimioterapia, Vol. 26, Núm. 1, pp. 45-51

2022

  1. A Dalbavancin Lock Solution Can Reduce Enterococcal Biofilms After Freezing

    Infectious Diseases and Therapy, Vol. 11, Núm. 2, pp. 743-755

  2. Correction to: A Dalbavancin Lock Solution Can Reduce Enterococcal Biofilms After Freezing (Infectious Diseases and Therapy, (2022), 11, 2, (743-755), 10.1007/s40121-021-00579-4)

    Infectious Diseases and Therapy

  3. Different performance of three point-of-care SARS-CoV-2 antigen detection devices in symptomatic patients and close asymptomatic contacts: a real-life study

    Clinical Microbiology and Infection, Vol. 28, Núm. 6, pp. 865-870

  4. High incidence of COVID-19 at nursing homes in Madrid, Spain, despite preventive measures

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 3, pp. 288-292

  5. Increase in the frequency of catheter-related bloodstream infections during the COVID-19 pandemic: a plea for control

    Journal of Hospital Infection, Vol. 119, pp. 149-154

  6. Nosocomial Transmission of SARS-CoV-2 Involving Vaccinated Health Care Workers

    Microbiology Spectrum, Vol. 10, Núm. 1

  7. Production of biofilm by Staphylococcus aureus: Association with infective endocarditis?

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 8, pp. 418-422

2021

  1. Endotracheal tubes coated with a broad-spectrum antibacterial ceragenin reduce bacterial biofilm in an in vitro bench top model

    The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 5, pp. 1168-1173

  2. Inference of active viral replication in cases with sustained positive reverse transcription-PCR results for SARS-CoV-2

    Journal of Clinical Microbiology, Vol. 59, Núm. 2

  3. Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity

    Mycoses, Vol. 64, Núm. 2, pp. 132-143

2020

  1. Colonization of the nasal airways by Staphylococcus aureus on admission to a major heart surgery operating room: A real-world experience

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 10, pp. 466-470

  2. In Vitro Study to Evaluate the Bioactivity of Freezing a Heparin-Based Dalbavancin Lock Solution

    Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 12

  3. Outbreak of COVID-19 in a nursing home in Madrid

    Journal of Infection

  4. Selective digestive decontamination solution used as "lock therapy" prevents and eradicates bacterial biofilm in an in vitro bench-top model

    Annals of clinical microbiology and antimicrobials, Vol. 19, Núm. 1, pp. 44

2019

  1. Correction: Is heparinized 40% ethanol lock solution efficient for reducing bacterial and fungal biofilms in an in vitro model(PLOS ONE(2019) 14:8(e0221702)DOI:10.1371/journal.pone.0219098)

    PLoS ONE